Immunocytochemical and pharmacological characterisation of P2-purinoceptor-mediated cell growth and death in PC-3 hormone refractory prostate cancer cells

Anticancer Research

Volumn 24, Issue 5 A, 2004, Pages 2853-2859

  Calvert, Robert C ^a   Shabbir, Majid ^b   Thompson, Cecil S ^c   Mikhailidis, Dimitri P ^c   Morgan, Robert J ^c   Burnstock, Geoffrey ^c  

^a BEDFORD HOSPITAL   (United Kingdom)

^b ROYAL FREE HOSPITAL   (United Kingdom)

^c ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

P2 purinoceptor mediated cell growth; Prostate cancer cells; Purinergic receptors

Indexed keywords

ADENOSINE TRIPHOSPHATE; PURINE P2 RECEPTOR; PURINE P2X3 RECEPTOR; PURINE P2X4 RECEPTOR; PURINE P2X5 RECEPTOR; PURINE P2X7 RECEPTOR; PURINE P2Y2 RECEPTOR;

APOPTOSIS; ARTICLE; CANCER CELL; CANCER GROWTH; CELL DEATH; CELL GROWTH; CONTROLLED STUDY; EXTRACELLULAR SPACE; GROWTH INHIBITION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IN VITRO STUDY; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN FUNCTION; RECEPTOR INTRINSIC ACTIVITY;

ADENOSINE TRIPHOSPHATE; APOPTOSIS; CELL DIVISION; CELL LINE, TUMOR; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; MALE; PROSTATIC NEOPLASMS; RECEPTORS, PURINERGIC P2; RNA;

EID: 6444231782     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Hamdy FC and Thomas BG: New therapeutic concepts in prostate cancer. BJU Int 88 (Suppl 2): 43-48, 2001.
2. Crawford ED, Rosenblum M, Ziadi AM and Lange PH: Overview: Hormone refractory prostate cancer. Urology 54: 1-7, 1999.
3. Abbracchio MP and Burnstock G: Purinergic signalling: Pathophysiological roles. Jpn J Pharmacol 78: 113-145, 1998.
4. Burnstock G: Potential therapeutic targets in the rapidly expanding files of purinergic signalling. Clin Med 2: 45-53, 2002.
5. Fang W-G, Pirnia F, Bang Y-J, Myers CE and Trepel JB: P2-purinergic receptor agonists inhibit the growth of androgen-independent prostate carcinoma cells. J Clin Invest 89: 191-196, 1992.
6. Janssens R and Boeynaems J-M: Effect of extracellular nucleotides and nucleoside on prostate carcinoma cells. Br J Pharmacol 132: 536-54, 2001.
7. Burnstock G: Introduction: ATP and its metabolites as potent extracellular agonists. In: Purinergic Receptors and Signalling. Academic Press, San Diego, 2003.
8. Lee H-Y, Bardini M and Burnstock G: P2X receptor immunoreactivity in the male genital organ of the rat. Cell Tissue Res 300: 295-306, 2000.
9. Bo X, Zhang Y, Nassar M, Burnstock G and Schoepfer R: A P2X purinoceptor cDNA conferring a novel pharmacological profile. FEES Lett 375: 129-133, 1995.
10. Neary JT, Rathbone MP, Cattebeni F, Abbracchio MP and Burnstock G: Trophic actions of extracellular nucleotides and nucleosides on glial and neuronal cells. Trend Neurosci 19: 13-18
11. Greig AVH, Linge C, Terenghi G, McGrouther DA and Burnstock G: Purinergic receptors are part of a functional signalling system for proliferation and differentiation of human epidermal keratinocytes. J Invest Dermatol 120: 1007-1015, 2003.
12. Coutinho Suva R, Persichini PM, Bisaggio JL, Perfettini AC, Neto JM, Kanellopoulos I, Motta Ly A, Dautry Varsat and Ojcius DM: P2Z/P2X7 receptor-dependent apoptosis of dendritic cells. Am J Phys 276: C1139-C1147, 1999.
13. Humphreys BD, Rice J, Kertsey SB and Dubyak GR: Stress-activated protein kinase/JNK activation and apoptotic induction by the macrophage P2X7 nucleotide receptor. J Biol Chem 275: 26792-26798, 2000.
14. Gröschel-Stewart U, Bardini M, Robson T and Burnstock G: Localisation of P2X5 and P2X7 receptors by immunohistochemistry in rat stratified squamous epithelia. Cell Tissue Res 296: 599-605, 1999.
15. Ryten M, Dunn PM, Neary JT and Burnstock G: ATP regulates the differentiation of mammalian skeletal muscle by activation of a P2X5 receptor on satellite cells. J Cell Biol 158: 345-355, 2002.
16. Trams EJ, Kauffman H and Burnstock G: A proposal for the role of ecto-enzymes and adenylates in traumatic shock. J Theor Biol 87: 609-621, 1980.
17. Bodin P and Burnstock G: ATP-stimulated release of ATP by human endothelial cells. J Cardiovasc Pharmacol 27: 872-875, 1996.
18. Rapaport E and Fontain J: Anticancer activities of adenine nucleotides in mice are mediated through expansion of erythrocyte ATP pools. Proc Natl Acad Sci 86: 1662-1666, 1988.
19. Agteresch HJ, Dagnelie PC, van der Gaast A, Stijnen T and Wilson JH: Randomized clinical trial of adenosine 5′-triphosphate in patients with advanced non-small-cell lung cancer. J Natl Cancer Inst 92: 290-291, 2000.